Judge David Herndon Archives - Carey Danis & Lowe

Pradaxa MDL News: Manufacturer Fined for Neglectful Document Handling

By | Pharmaceutical litigation, Pradaxa, Uncategorized

pradaxa_lawsuitIn a federal Illinois court, Boehringer Ingelheim has been fined $1 million for neglecting to retain documents pertinent to a multidistrict litigation (MDL). It is unclear if the German pharmaceutical company can be accused of destroying or withholding the Pradaxa documents.

The fine was brought down upon Boehringer Ingelheim in the U.S. District Court for the Southern District of Illinois in the Pradaxa MDL.

U.S. District Judge David Herndon, who handed the manufacturer of Pradaxa the fine, called Boehringer Ingelheim’s practices regarding document retention outrageously neglectful.

According to Bloomberg, there are approximately over 1,700 Pradaxa bleeding lawsuits pending in the federal Illinois court. Plaintiffs have filed Pradaxa lawsuits alleging incidences of excessive loss of blood. When these excessive bleeding episodes become uncontrollable, they may become fatal, resulting in what is called a bleed-out death.

A blood-thinning agent, Pradaxa is a drug used to prevent incidences of blood clots and stroke in patients with atrial fibrillation.

The Pradaxa MDL is In re: Pradaxa Products Liability Litigation MDL no. 2385, and is being heard in East St. Louis, Illinois.

In addition to the Pradaxa MDL in Illinois, individuals who believe that they have been injured by the use of Pradaxa have filed lawsuits targeted at Boehringer Ingelheim from coast to coast, in Delaware, Connecticut, and California. There are also Pradaxa bleeding lawsuits pending in state courts in Illinois.

National Law Firm Representing Pradaxa Victims

As a national law firm headquartered in St. Louis that provides legal counsel to victims of defective drugs, Carey Danis & Lowe Pradaxa attorneys are currently investigating Pradaxa cases. If you believe that your injuries are the result of Pradaxa use, explore your legal options with one of our Pradaxa attorneys at Carey Danis & Lowe today.

We also have a team of highly experienced nurses and medical experts who are available to listen closely to your concerns about Pradaxa as it concerns patient health and safety.

Share your Pradaxa story with Carey Danis & Lowe today. Call 800.721.2519, or submit a confidential personal injury claim form.

Bayer Allocates $1.5 Billion as a Yaz and Yasmin Legal Fund: Settlement Agreements Reached in Yaz and Yasmin Lawsuits

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

Bayer Allocates $1.5 Billion as a Yaz and Yasmin Legal Fund: Settlement Agreements Reached in Yaz and Yasmin Lawsuits According to a Reuters report published on March 4, Bayer allocated $1.5 billion last year as a legal fund for Yaz and Yasmin lawsuits. In anticipation of future settlements of Yaz and Yasmin lawsuits, Bayer has set these funds aside, as it faces thousands more lawsuits.

Bayer recently reached a settlement agreement of $1 billion in 4,800 lawsuits filed against them in the U.S. These nearly 5,000 lawsuits were filed against the German pharmaceutical company because, as the plaintiffs claim, ingestion of the contraceptives Yaz and Yasmin resulted in the formation of blood clots causing heart attack, stroke, and even death.

Though Bayer has settled these 4,800 Yaz and Yasmin lawsuits, they still face over 11,000 more in the U.S. alone. In Canada, the manufacturer of Yaz and Yasmin will be up against 13 class action lawsuits.

A Yaz multi-district litigation (MDL) has been established in a U.S. District Court for the Southern District of Illinois. Yaz and Yasmin lawsuits have been consolidated into the MDL, which is known as In re Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation MDL 2100. The Yaz MDL 2100 is being overheard by Judge David Herndon, who in 2011 postponed bellwether trials.

Lawyers at Carey Danis & Lowe have been following the Yaz and Yasmin MDL in order to determine if the MDL proceedings will be affected at all by any recent Yaz and Yasmin settlements or other actions made by Bayer, such as their most recent public move in allocating over $1 billion for legal expenses.

Women who have filed Yaz and Yasmin lawsuits have experienced serious health complications, some of which have been fatal. Plaintiffs in these lawsuits allege that Bayer, in addition to releasing a defective, harmful drug onto the market, are also guilty of withholding information about the health risks of using these two contraceptive drugs along with employing deceptive marketing practices.

Lawyers at Carey Danis & Lowe encourage women who have been injured by Yaz or Yasmin to contact an experienced trial lawyer at Carey Danis & Lowe today for a free legal evaluation about a Yaz and Yasmin case. As Bayer’s most recent fund transfer demonstrates, they are preparing to settle these lawsuits as opposed to fighting them.

To file a Yaz lawsuit or a Yasmin lawsuit, contact a lawyer at Carey Danis & Lowe today by calling 800.721.2519 or by submitting a legal claim form.